10x genomics stock price.

According to 10 stock analysts, the average 12-month stock price forecast for 10x Genomics stock is $58.6, which predicts an increase of 33.85%. The lowest target is $30 and the highest is $75. On average, analysts rate 10x Genomics stock as a buy.10x Genomics last issued its earnings results on November 2nd, 2023. The reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.45) by $0.06. The business had revenue of $153.64 million for the quarter, compared to the consensus estimate of $150.11 million. 10x Genomics has generated ($1.91) …10x Genomics Inc Ordinary Shares - Class A TXG Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials...10x Genomics Inc experienced a daily loss of 5.62% and a 3-month loss of 12.81%.The company also reported a Loss Per Share of 1.49. Despite these figures, we aim to explore whether the stock is ...Barclays reduced their price target on shares of 10x Genomics from $66.00 to $47.00 and set an “overweight” rating for the company in a research report on Friday, September 29th. Finally, Citigroup boosted their price target on shares of 10x Genomics from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday ...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Buy. 64.3%. Hold. 21.4%. Sell. 14.3%. View the real-time TXG price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd.co/fees to learn more.

8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.Analyst Michael Ryskin of Bank of America Securities reiterated a Sell rating on 10x Genomics (TXG – Research Report), with a price target of $36.00. Michael Ryskin has given his Sell rating due ...

10x Genomics stock opened at $34.93 on Monday. The firm's market capitalization is $4 billion, its price-to-earnings ratio is -23.60, and its beta is 1.70.TXG 10x Genomics Inc - Class A Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ)8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ.

10x Genomics is bordering on breakeven, according to the 12 American Life Sciences analysts. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$6 ...

Great news for investors – 10x Genomics is still trading at a fairly cheap price. My valuation model shows that the intrinsic value for the stock is $60.88, but it is currently trading at US$38. ...

Information on stock, financials, earnings, subsidiaries, investors, and executives for 10x Genomics. Use the PitchBook Platform to explore the full profile.10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75%. (Simply Wall St.) Dec-08-22 04:05PM. 10x Genomics Commercially Launches Xenium Platform for In Situ Analysis. (PR Newswire) +7.27%. PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first commercial ...Sep 18, 2023 · 10x Genomics appears to be significantly undervalued based on the GF Value calculation. At its current price of $47.68 per share, the stock's long-term return is likely to be much higher than its ... Financials. 10X Genomics reported $134.3M in revenue for Q1, up 17% from $114.5M from Q1 of 2022. OpEx came in at $150.4M for Q1, a 15% increase year-over-year. This led to an operating loss of ...

PLEASANTON, Calif., Nov. 2, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended ...We have become the latest target in a string of attacks by a company (10x Genomics, NASDAQ: TXG) with a history of bringing litigation against smaller, …Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to …Q4 2022 revenue growth of 9% and FY 2022 revenue growth of 5% over the corresponding periods of 2021. PLEASANTON, Calif., Feb. 15, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided outlook for 2023.Financials. 10X Genomics reported $134.3M in revenue for Q1, up 17% from $114.5M from Q1 of 2022. OpEx came in at $150.4M for Q1, a 15% increase year-over-year. This led to an operating loss of ...10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75%. (Simply Wall St.) Dec-08-22 04:05PM. 10x Genomics Commercially Launches Xenium Platform for In …Oct 10, 2019 · 10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023 PR Newswire - Wed Oct 11, 3:05PM CDT. /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the third... TXG : 38.51 (-1.13%)

Real time 10x Genomics (TXG) stock price quote, stock graph, news & analysis.The case marks 10x Genomics' ( TXG) legal challenge to assert its patent rights. In November, a jury in Delaware found that Washington-based life sciences firm …

Based on short-term price targets offered by 12 analysts, the average price target for 10x Genomics comes to $56.00. The forecasts range from a low of $30.00 to a high of $70.00. The average price ...Don’t write all synthetic biology stocks off just because the meme stocks crashed and burned! Here are 3 DNA stocks to buy for the synthetic biology revolution. TXG. 10x Genomics. $52.64. CRL ...10x Genomics, Inc. (TXG) Stock Price, Quote & News - Stock Analysis 43.36 +0.01 (0.02%) At close: Nov 24, 2023, 1:00 PM 43.07 -0.29 (-0.67%) After-hours: …TXG | Complete 10x Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at June 2023, 10x Genomics had cash of US$391m ...10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75%. (Simply Wall St.) Dec-08-22 04:05PM. 10x Genomics Commercially Launches Xenium Platform for In Situ Analysis. (PR Newswire) +7.27%.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Regardless, money keeps flowing into the gene editing space, and these three CRISPR stocks are worthy of investors’ attention going forward. CRSP. CRISPR. $57.47. EDIT. Editas. $11.70. TXG. 10x ...

21.61M. MSFT. 377.43. -0.11%. 9.38M. View today's 10X Genomics Inc stock price and latest TXG news and analysis. Create real-time notifications to follow any changes in the live stock price.9/12/2023 10x Genomics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 84. ... Stocks To Watch: 10x Genomics Sees Relative Strength Rating Rise To 93;ALLISON GATLIN. 04:08 PM ET 07/15/2022. TXG stock crashed Friday after genetic technology outlet 10x Genomics ( TXG) preannounced lackluster second-quarter sales. The company noted declines for ...A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at June 2023, 10x Genomics had cash of US$391m ...Buy 10X Genomics Stock. 10X Genomics is a health information services business based in the US. 10X Genomics shares (TXG.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $45.75 – an increase of 5.12% over the previous day. 10X Genomics employs 1,243 staff and has a trailing 12-month revenue of ...Buy. 64.3%. Hold. 21.4%. Sell. 14.3%. View the real-time TXG price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd.co/fees to learn more.9/12/2023 10x Genomics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 84. ... Stocks To Watch: 10x Genomics Sees Relative Strength Rating Rise To 93;ALLISON GATLIN. 04:08 PM ET 07/15/2022. TXG stock crashed Friday after genetic technology outlet 10x Genomics ( TXG) preannounced lackluster second-quarter sales. The company noted declines for ...Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can...Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensNov 30, 2023 · The 10x Genomics, Inc. stock price gained 0.462% on the last trading day (Thursday, 30th Nov 2023), rising from $43.32 to $43.52. During the last trading day the stock fluctuated 2.39% from a day low at $42.67 to a day high of $43.69. The price has risen in 6 of the last 10 days and is up by 7.7% over the past 2 weeks. 10x Genomics stock went public in September. Since then, shares of the genetic-testing company have rocketed more than 65%.

8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.CI. UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Instagram:https://instagram. list sandp 500 stocksbest fidelity foreign fundsbest lenders for commercial real estateis arm ipo a buy Feb. 22, 2022, 04:15 PM. PLEASANTON, Calif ,, Feb. 22, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today ... nasdaq rekrexxon mobil corporation dividend Shares of 10x Genomics are in a yearlong rut. After the company went public in 2019, its shares soared to a peak in mid-2021. Since then, however, TXG stock has generally trended down.10 stocks we like better than 10x Genomics When investing geniuses David and Tom Gardner have a stock tip, ... Brian, is that 10x Genomics is one of those stocks that's just priced for perfection ... how to buy preferred stock 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene ...What is the target price for 10x Genomics (TXG) stock? The latest price target for 10x Genomics ( NASDAQ: TXG) was reported by Barclays on Friday, September 29, 2023. The analyst firm set a price ... A full transcript follows the video. 10 stocks we like better than 10x Genomics Inc. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter ...